New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

NeOnc Technologies Holdings, Inc.

Contributing Author

Recent Articles by NeOnc Technologies Holdings, Inc.

Sep-10	NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 - A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer NTHI GlobeNewswire
Aug-25	NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board NTHI GlobeNewswire
Aug-19	NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update NTHI GlobeNewswire
Aug-11	NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation NTHI GlobeNewswire
Aug-07	NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia NTHI GlobeNewswire
Aug-04	NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer NTHI GlobeNewswire
Jul-30	NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors NTHI GlobeNewswire
Jul-29	NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-28	NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference NTHI GlobeNewswire
Jul-23	CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc. NTHI GlobeNewswire
Jul-23	NeOnc Technologies' Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks - Today at 11:00 a.m. ET NTHI GlobeNewswire
Jul-22	NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-10	NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-09	NeOnc Technologies Holdings, Inc. Joins Russell Microcap Index NTHI GlobeNewswire
Jul-08	NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform NTHI GlobeNewswire
Jun-06	NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs NTHI GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.